Nuvation Bio
Manufacturing · New York, United States · 201-500 Employees
View Company Info for Free
Overview
Headquarters
1500 Broadway Ste 1401, New York, New Yo...Phone Number
(332) 208-6102Website
www.nuvationbio.comRevenue
$169.9 MillionStock Symbol
NUVBIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
2
1
1
1
1
1
About Nuvation Bio
Nuvation Bio is a global biopharmaceutical company focused on treating patients with the most difficult-to-treat cancers for which conventional therapies have failed. Nuvation Bio is a global biopharmaceutical company tackling some of the greatest unmet needs in oncology by developing differentiated and novel product candidates.Explore more
Nuvation Bio Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Nuvation Bio your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Nuvation Bio
Check if Nuvation Bio has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Nuvation Bio recently announced quarterly report
Nuvation Bio, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Nuvation Bio has new funding data
Check out if Nuvation Bio is spiking on competitors!
Website visits: Recent activity has been detected on your website
Click to see if Nuvation Bio had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Nuvation Bio launches new products
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to Nuvation Bio
Compare insights from companies similar to Nuvation Bio, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Nuvation Bio is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Nuvation Bio is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Nuvation Bio.
Nuvation Bio financials insights
Gather financial insights about Nuvation Bio, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2019
Series A
$275M
2025
Other Financing Round
$250M
Nuvation Bio Tech Stack
A closer look at the technologies used by Nuvation Bio
See more technologies
Most Recent Scoops
Person-Based
Earnings, Finance
Person-Based
Earnings, Finance
Earnings
Earnings, Finance
Earnings
Earnings, Finance
Open Position
Nuvation Bio News & Media
Nuvation Bio Inc. (NUVB) Presents at 12th Annual Cantor Fitzgerald Global Healthcare Conference Transcript
Nuvation Bio Inc. (NUVB) 12th Annual Cantor Fitzgerald Global Healthcare Conference September 10, 2026 1:35 PM EDTCompany ParticipantsDavid Hung - Founder,...Nuvation Bio Announces New Analyses Reinforcing the Durable, Consistent Efficacy of IBTROZI® (taletrectinib) Across Key Patient Subgroups in Advanced ROS1+ NSCLC at 2026 World Conference on Lung Cancer
Long-term pooled data from the pivotal TRUST-I and TRUST-II studies showed similar efficacy, including duration of response and progression-free survival, between CD74 and non-CD74 ROS1 fusion-partner subgroups Among patients who received IBTROZI after prior chemotherapy, response rates...Nuvation Bio to Participate in Upcoming Investor Conferences
NEW YORK, Sept. 2, 2026 /PRNewswire/ -- Nuvation Bio Inc. (NYSE: NUVB), a global oncology company focused on tackling some of the toughest challenges in cancer treatment, today announced that David Hung, M.D., Founder, President, and Chief Executive Officer of Nuvation Bio, and Philippe...Nuvation Bio Granted FDA Fast Track Designation for Safusidenib for Treatment of IDH1-Mutant Glioma
Designation offers pathway to expedite regulatory review, pending positive data, and reinforces safusidenib's potential to address significant medical needs for patients with IDH1-mutant glioma Pivotal Phase 3 SIGMA study enrollment underway NEW YORK, Aug. 20, 2026 /PRNewswire/ --...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding Nuvation Bio
Sign Up For FreeTo access detailed company insights
Nuvation Bio is a global biopharmaceutical company focused on treating patients with the most difficult-to-treat cancers for which conventional therapies have failed. Nuvation Bio is a global biopharmaceutical company tackling some of the greatest unmet needs in oncology by developing differentiated and novel product candidates.... Read More
